Home/Filings/4/0001213900-20-016299
4//SEC Filing

Brown Dennis M 4

Accession 0001213900-20-016299

CIK 0001498382other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:07 PM ET

Size

11.2 KB

Accession

0001213900-20-016299

Insider Transaction Report

Form 4
Period: 2020-06-26
Brown Dennis M
DirectorChief Scientific Officer10% Owner
Transactions
  • Award

    Options (Right to Buy)

    2020-06-26+52,756100,000 total
    Exercise: $0.61Exp: 2029-09-05Common Stock (52,756 underlying)
  • Other

    Common Stock

    2020-06-30+176,011 total
  • Award

    Options (Right to Buy)

    2020-06-26+250,000250,000 total
    Exercise: $0.73Exp: 2029-11-12Common Stock (250,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    53,750
Footnotes (6)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
  • [F2]Held by Valent Technologies LLC, of which the reporting person is the sole member and owner and holds sole voting and dispositive power over its shares.
  • [F3]On September 5, 2019, the reporting person received options to purchase 52,756 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020.
  • [F4]1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020.
  • [F5]On November 12, 2019, the reporting person received options to purchase 250,000 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020.
  • [F6]The options vested based on the achievement of certain clinical milestones.

Documents

1 file

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001569520

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:07 PM ET
Size
11.2 KB